Alopecia areata as another immune-mediated disease developed in patients treated with tumour necrosis factor-α blocker agents

Alopecia Areata following Adalimumab

(2015) Carly Kirshen et al.   JOURNAL OF CUTANEOUS MEDICINE AND SURGERY

Psoriasiform eruption associated with alopecia areata during infliximab therapy

(2009) D. Nakagomi et al.   CLINICAL AND EXPERIMENTAL DERMATOLOGY

Alopecia Areata During Etanercept Therapy

(2009) Ying Pan et al.   OCULAR IMMUNOLOGY AND INFLAMMATION

Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: A literature review and potential mechanisms of action

(2008) Angelique N. Collamer et al.   ARTHRITIS AND RHEUMATISM

Autoimmune diseases induced by TNF-targeted therapies

(2008) Manuel Ramos-Casals et al.   BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY

Biologic Agents and Alopecia Areata

(2008) A.C. Katoulis et al.   DERMATOLOGY

Alopecia Areata Universalis Elicited during Treatment with Adalimumab

(2008) Nedzmidin Pelivani et al.   DERMATOLOGY

Worsening Alopecia Areata and de novo Occurrence of Multiple Halo Nevi in a Patient Receiving Infliximab

(2008) C. Fabre et al.   DERMATOLOGY

Alopecia Areata Universalis during Treatment of Rheumatoid Arthritis with Anti-TNF-α Antibody (Adalimumab)

(2008) Y. Chaves et al.   DERMATOLOGY